180 related articles for article (PubMed ID: 19615789)
1. Synthesis and anabolic/androgenic evaluation of novel 9alpha-fluorosteroids.
Reyes-Moreno M; Ruiz-García JA; Ibarra-Reyes Y; Fuente-Hernández A; Vélez-Castro H; Hernández-Balmaseda I; Martínez-Hormaza I; Rodeiro-Guerra I; Ramírez JS; Reyes SM; Montiel-Smith S
Eur J Med Chem; 2009 Nov; 44(11):4567-71. PubMed ID: 19615789
[TBL] [Abstract][Full Text] [Related]
2. The effects of 5alpha-reduced androgens on maintenance and regeneration of prostate glands and seminal vesicles in castrated and hypophysectomized rats.
Ahmad N; Warren DW; Haltmeyer GC
Anat Rec; 1978 Dec; 192(4):543-54. PubMed ID: 736274
[TBL] [Abstract][Full Text] [Related]
3. New steroidal derivatives synthesized using 3beta-hydroxyandrosten-17-one as starting material.
Abd El-Latif NA; Abdulla MM; Amr Ael-G
Acta Pharm; 2008 Mar; 58(1):43-59. PubMed ID: 18337207
[TBL] [Abstract][Full Text] [Related]
4. Long-term effects of dimethandrolone 17β-undecanoate and 11β-methyl-19-nortestosterone 17β-dodecylcarbonate on body composition, bone mineral density, serum gonadotropins, and androgenic/anabolic activity in castrated male rats.
Attardi BJ; Marck BT; Matsumoto AM; Koduri S; Hild SA
J Androl; 2011; 32(2):183-92. PubMed ID: 20798389
[TBL] [Abstract][Full Text] [Related]
5. 5Alpha-androstane-3beta,7alpha,17beta-triol and 5alpha-androstane-3beta,7beta,17beta-triol as substrates for the human 11beta-hydroxysteroid dehydrogenase type 1.
Hennebert O; Le Mée S; Pernelle C; Morfin R
Steroids; 2007 Nov; 72(13):855-64. PubMed ID: 17825335
[TBL] [Abstract][Full Text] [Related]
6. Cycloprop(16 ,17 )androstanes.
Fahrenholtz KE; Meyes KP; Kierstead RW
J Med Chem; 1972 Oct; 15(10):1056-60. PubMed ID: 5069774
[No Abstract] [Full Text] [Related]
7. Anabolic and androgenic activities of 19-nor-testosterone steroids: QSAR study using quantum and physicochemical molecular descriptors.
Alvarez-Ginarte YM; Montero-Cabrera LA; de la Vega JM; Noheda-Marín P; Marrero-Ponce Y; Ruíz-García JA
J Steroid Biochem Mol Biol; 2011 Aug; 126(1-2):35-45. PubMed ID: 21514384
[TBL] [Abstract][Full Text] [Related]
8. In vivo uptake and metabolism of 3-h-5alpha-androstane-3alpha,17beta-diol and of 3-h-5alpha-androstane-3beta,17beta-diol by human prostatic hypertrophy.
Horst HJ; Dennis M; Kaufmann J; Voigt KD
Acta Endocrinol (Copenh); 1975 Jun; 79(2):394-402. PubMed ID: 49141
[TBL] [Abstract][Full Text] [Related]
9. The altered specificity of cortisone reductase with certain retroandrostan-3-one substrates.
Gibb W; Jeffery J
Biochem J; 1975 Mar; 145(3):483-9. PubMed ID: 168869
[TBL] [Abstract][Full Text] [Related]
10. Prolactin influences upon androgen action in male accessory sex organs.
Thomas JA; Keenan EJ
Adv Sex Horm Res; 1976; 2():425-70. PubMed ID: 189591
[TBL] [Abstract][Full Text] [Related]
11. [Experimental study of the anabolic activity of 6-ketoderivatives of certain natural sapogenins].
Syrov VN; Kurmukov AG
Farmakol Toksikol; 1976; 39(5):631-5. PubMed ID: 1028596
[TBL] [Abstract][Full Text] [Related]
12. 7alpha,11beta-Dimethyl-19-nortestosterone: a potent and selective androgen response modulator with prostate-sparing properties.
Cook CE; Kepler JA
Bioorg Med Chem Lett; 2005 Feb; 15(4):1213-6. PubMed ID: 15686944
[TBL] [Abstract][Full Text] [Related]
13. 17beta-hydroxy-5alpha-androst-1-en-3-one (1-testosterone) is a potent androgen with anabolic properties.
Friedel A; Geyer H; Kamber M; Laudenbach-Leschowsky U; Schänzer W; Thevis M; Vollmer G; Zierau O; Diel P
Toxicol Lett; 2006 Aug; 165(2):149-55. PubMed ID: 16621347
[TBL] [Abstract][Full Text] [Related]
14. 5alpha-Androstane-3beta,17beta-diol (3beta-diol), an estrogenic metabolite of 5alpha-dihydrotestosterone, is a potent modulator of estrogen receptor ERbeta expression in the ventral prostrate of adult rats.
Oliveira AG; Coelho PH; Guedes FD; Mahecha GA; Hess RA; Oliveira CA
Steroids; 2007 Dec; 72(14):914-22. PubMed ID: 17854852
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of 4-hydroxyandrostenedione and 4-hydroxytestosterone: Mass spectrometric identification of urinary metabolites.
Kohler M; Parr MK; Opfermann G; Thevis M; Schlörer N; Marner FJ; Schänzer W
Steroids; 2007 Mar; 72(3):278-86. PubMed ID: 17207827
[TBL] [Abstract][Full Text] [Related]
16. Anabolic-androgenic activity of A-ring modified androstane derivatives. I. A comparison of parenteral activity.
Nutting EF; Klimstra PD; Counsell RE
Acta Endocrinol (Copenh); 1966 Dec; 53(4):627-34. PubMed ID: 6012541
[No Abstract] [Full Text] [Related]
17. Investigations on steroids. IX. Pharmacological studies. (3). Myotrophic and androgenic activities of 17beta-hydroxy-5alpha-androstano-[2,3-c]furazan and its derivatives.
Kasahara A; Onodera T; Oshima Y; Shimizu M
Chem Pharm Bull (Tokyo); 1968 Aug; 16(8):1456-9. PubMed ID: 5708248
[No Abstract] [Full Text] [Related]
18. Efficient approach to novel 1α-triazolyl-5α-androstane derivatives as potent antiproliferative agents.
Kádár Z; Baji Á; Zupkó I; Bartók T; Wölfling J; Frank É
Org Biomol Chem; 2011 Dec; 9(23):8051-7. PubMed ID: 21979462
[TBL] [Abstract][Full Text] [Related]
19. The determination of 5alpha-androstane-3alpha, 17beta-diol in human plasma by radioimmunoassay.
Laband P; Tresguerres JA; Lisboa BP; Volkwein U; Tamm J
Acta Endocrinol (Copenh); 1978 Aug; 88(4):778-86. PubMed ID: 581118
[TBL] [Abstract][Full Text] [Related]
20. Heterocyclic steroids. 5. Sulfur, selenium, and tellurium 5alpha-androstane derivatives and their 7alpha-methylated congeners.
Zanati G; Gaare G; Wolff ME
J Med Chem; 1974 May; 17(5):561-3. PubMed ID: 4830264
[No Abstract] [Full Text] [Related]
[Next] [New Search]
